Pancreatic β-cell fate in subjects with COVID-19

Two recent reports denoted the potential of SARS-CoV-2 to directly infect beta-cells and the possible fate of beta-cells under COVID-19. The fight against SARS-CoV-2 will continue to develop more effective therapeutic strategies for diabetes.

Automated summary

Recent reports highlight the potential direct infection of beta-cells by SARS-CoV-2 and the impact on diabetes patients under COVID-19. Developing more effective therapeutic strategies remains crucial in the fight against the virus.